- Home
- PROF
as 06-20-2025 3:40pm EST
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.
| Founded: | N/A | Country: | Canada |
| Employees: | N/A | City: | MISSISSAUGA |
| Market Cap: | 149.7M | IPO Year: | N/A |
| Target Price: | $11.50 | AVG Volume (30 days): | 50.0K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.22 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.90 - $11.42 | Next Earning Date: | 08-07-2025 |
| Revenue: | $11,862,000 | Revenue Growth: | 75.01% |
| Revenue Growth (this year): | 71.17% | Revenue Growth (next year): | 134.25% |
Stock Insider Trading Activity of Profound Medical Corp. (PROF)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Menawat Arun Swarup | PROF | CEO | May 15 '25 | Buy | $4.53 | 22,030 | $100,150.69 | 575,062 |
Latest Profound Medical Corp. News
PROF Breaking Stock News: Dive into PROF Ticker-Specific Updates for Smart Investing
GlobeNewswire
11 days ago
Profound Medical Announces First Commercial BPH Patient Treatment Using TULSA-PRO® with TULSA-AI® Volume Reduction
GlobeNewswire
17 days ago
Famed Former NFL Safety, Leonard Wheeler, Named Global Ambassador For TULSA-PRO®
Simply Wall St.
a month ago
Arun Menawat Bought 2.1% More Shares In Profound Medical
GlobeNewswire
a month ago
Profound Medical Annual General and Special Meeting of Shareholders Voting Results
Simply Wall St.
a month ago
Profound Medical First Quarter 2025 Earnings: Misses Expectations
GuruFocus.com
a month ago
Profound Medical Corp (PROF) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic ...
GlobeNewswire
a month ago
Profound Medical Announces First Quarter 2025 Financial Results
GuruFocus.com
a month ago
Profound Medical Corp (TSX:PRN) Q1 2025 Earnings Report Preview: What To Look For
Compare PROF vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PROF Profound Medical Corp. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.